In a new study, researchers developed a three-dimensional (3D) in vitro tissue model to assess the effects of SARS-CoV-2 on the vascular endothelial cells.

Remdesivir is an RNA polymerase inhibitor with potent antiviral activity in vitro and efficacy in animal models of coronavirus disease 2019 (Covid-19).We conducted a randomized, open-label, phase 3 ...

Opaganib 'completely inhibited' replication of the SARS-CoV-2 virus in in-vitro model of human bronchial tissue, Israeli firm says; study still to be submitted for peer review ...

Researchers from Tel Aviv University and the Israel Institute for Biological Research in Ness Ziona have used the platform ...

MONTREAL, Jan. 26, 2021 /CNW/ - An article titled "In vitro virucidal activity of Echinaforce®, an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E ...

A meta-analysis of 187 trials shows that Paxlovid and remdesivir reduce the risk for hospitalization in patients with mild-to ...

“Despite the huge efforts of researchers to develop machine learning models for COVID-19 diagnosis and prognosis, we found methodological flaws and many biases throughout the literature, leading ...

Mathematical models and computer simulations are the new frontiers in COVID-19 drug trials. ScienceDaily . Retrieved June 2, 2025 from www.sciencedaily.com / releases / 2021 / 07 / 210719103027.htm ...

The SEIR model is just one of several COVID-19 modelling efforts, and Lafferty is handling the day-to-day operations of the team, supporting EL Senior Research Scientist Dr. Todd Bridges, ...